Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J W Sweetenham
Economics of Stem Cell Transplantation for Lymphoma: Counting the Cost of Living
British Journal of Cancer
Cancer Research
Oncology
Autologous Transplantation Followed Closely by Reduced-Intensity Allogeneic Transplantation as Consolidative Immunotherapy in Advanced Lymphoma Patients: A Feasibility Study
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Infections Following Autologous Stem Cell Transplantation for Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Monoclonal Antibodies and Autologous Stem Cell Transplantation for Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Cost-Effectiveness Analysis of Consolidation With Brentuximab Vedotin for High-Risk Hodgkin Lymphoma After Autologous Stem Cell Transplantation
Cancer
Cancer Research
Oncology
Autologous Hematopoietic Stem Cell Transplantation for Plasmablastic Lymphoma: The European Society for Blood and Marrow Transplantation Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcomes of Autologous Stem Cell Transplantation for Lymphoma in the Elderly: A Single Center Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Stem Cell Transplantation in Follicular Lymphoma: Progress at Last?
Bone Marrow Transplantation
Transplantation
Hematology
Chronic Type Adult T-Cell Leukemia-Lymphoma After Autolougous Stem Cell Transplantation for ALK-negative Anaplastic Large Cell Lymphoma
Retrovirology
Virology
Infectious Diseases
Cost Effectiveness of Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for the First-Line Treatment of Mantle Cell Lymphoma Not Eligible for Stem Cell Transplantation: A Scottish Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
